BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25005329)

  • 1. A systematic review of bone mineral density and fractures in phenylketonuria.
    Hansen KE; Ney D
    J Inherit Metab Dis; 2014 Nov; 37(6):875-80. PubMed ID: 25005329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between lumbar bone mineral density and biochemical parameters in phenylketonuria patients.
    de Groot MJ; Hoeksma M; van Rijn M; Slart RH; van Spronsen FJ
    Mol Genet Metab; 2012 Apr; 105(4):566-70. PubMed ID: 22300845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone health in phenylketonuria: a systematic review and meta-analysis.
    Demirdas S; Coakley KE; Bisschop PH; Hollak CE; Bosch AM; Singh RH
    Orphanet J Rare Dis; 2015 Feb; 10():17. PubMed ID: 25758373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased bone mineral density in children with phenylketonuria.
    Allen JR; Humphries IR; Waters DL; Roberts DC; Lipson AH; Howman-Giles RG; Gaskin KJ
    Am J Clin Nutr; 1994 Feb; 59(2):419-22. PubMed ID: 8310995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid profile in patients with phenylketonuria and its relationship with bone mineral density.
    Lage S; Bueno M; Andrade F; Prieto JA; Delgado C; Legarda M; Sanjurjo P; Aldámiz-Echevarría LJ
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S363-71. PubMed ID: 20830525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced bone mineral density in Chinese children with phenylketonuria.
    Wang K; Shen M; Li H; Li X; He C
    J Pediatr Endocrinol Metab; 2017 May; 30(6):651-656. PubMed ID: 28489557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone mineral density is within normal range in most adult phenylketonuria patients.
    Lubout CMA; Arrieta Blanco F; Bartosiewicz K; Feillet F; Gizewska M; Hollak C; van der Lee JH; Maillot F; Stepien KM; Wagenmakers MAEM; Welsink-Karssies MM; van Spronsen FJ; Bosch AM
    J Inherit Metab Dis; 2020 Mar; 43(2):251-258. PubMed ID: 31587319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mineral density in patients with phenylketonuria.
    Zeman J; Bayer M; Stepán J
    Acta Paediatr; 1999 Dec; 88(12):1348-51. PubMed ID: 10626520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review and meta-analysis of glucocorticoid-induced osteoporosis in children.
    Hansen KE; Kleker B; Safdar N; Bartels CM
    Semin Arthritis Rheum; 2014 Aug; 44(1):47-54. PubMed ID: 24680381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone Status in Patients with Phenylketonuria: A Systematic Review.
    de Castro MJ; de Lamas C; Sánchez-Pintos P; González-Lamuño D; Couce ML
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32698408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bone metabolism in adults with phenylketonuria - Hungarian data].
    Barta AG; Sumánszki C; Reismann P
    Orv Hetil; 2017 Nov; 158(47):1868-1872. PubMed ID: 29153023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated plasma phenylalanine concentrations may adversely affect bone status of phenylketonuric mice.
    Yannicelli S; Medeiros DM
    J Inherit Metab Dis; 2002 Sep; 25(5):347-61. PubMed ID: 12408184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and safety of vitamin D in relation to bone health.
    Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
    Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle and Bone Health in Young Chilean Adults with Phenylketonuria and Different Degrees of Compliance with the Phenylalanine Restricted Diet.
    Rojas-Agurto E; Leal-Witt MJ; Arias C; Cabello JF; Bunout D; Cornejo V
    Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low bone mineral density and fractures in stages 3-5 CKD: an updated systematic review and meta-analysis.
    Bucur RC; Panjwani DD; Turner L; Rader T; West SL; Jamal SA
    Osteoporos Int; 2015 Feb; 26(2):449-58. PubMed ID: 25477230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet.
    Solverson P; Murali SG; Litscher SJ; Blank RD; Ney DM
    PLoS One; 2012; 7(9):e45165. PubMed ID: 23028819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone development in children and adolescents with PKU.
    Mendes AB; Martins FF; Cruz WM; da Silva LE; Abadesso CB; Boaventura GT
    J Inherit Metab Dis; 2012 May; 35(3):425-30. PubMed ID: 22076426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis.
    Jamal SA; Hayden JA; Beyene J
    Am J Kidney Dis; 2007 May; 49(5):674-81. PubMed ID: 17472850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peak bone mass in patients with phenylketonuria.
    Modan-Moses D; Vered I; Schwartz G; Anikster Y; Abraham S; Segev R; Efrati O
    J Inherit Metab Dis; 2007 Apr; 30(2):202-8. PubMed ID: 17347917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.